'Vaccinations Should Not Be Free For Non-residents'
"); jQuery("#212 h3").html("

"); });
2022-12-26 HKT 12:10
A virologist at the University of Hong Kong, Jin Dong-yan, said on Monday he expects the opening of the border between Hong Kong and the mainland to bring "manageable risks" to the SAR, as he and the head of a pharmacists' group both called on authorities to consider charging non-residents for Covid vaccinations here.
Officials have said they aim to start allowing more people to flow through the Hong Kong-mainland border by the middle of next month.
"There's definitely risk as many big cities in mainland China are going through a tsunami phase, so they for sure have relatively more infected people," Jin said on an RTHK programme.
He pointed out that Hong Kong could see an increase in cases, as well as demand for vaccinations and antiviral drugs, when more people are allowed to cross the border.
"But I think all the risks are manageable and we should have a bit more confidence in ourselves," the professor in precision medicine added.
Jin said he believes infected incoming travellers will mostly have mild cases of Covid-19 and that PCR tests will be able to screen them out.
On the question of surging demand for drugs and vaccines, meanwhile, he had a proposal.
"As there are sufficient vaccines in the world, perhaps if we save up more and treat it as a business, that won't be a loss for us," the virologist said.
Non-residents who are not studying or working in Hong Kong should be charged for vaccinations, he continued.
Meanwhile, the president of The Society of Hospital Pharmacists, William Chui, also called on the government to charge non-residents for vaccinations, warning that free jabs and treatments could prompt too many to cross the border to access medical services here and burden the local system.
"People from mainland China demand for more symptomatic relief medications," he said. "They may go to Hong Kong to get more medications. At the moment they are looking for medications on the mainland but the supply is very limited."
Chui urged local pharmaceutical companies to quickly boost their production now in view of surging demand to come.
"The Hong Kong government should contact the local drug manufacturers to increase the manufacturing of paracetamol and also other symptomatic relief medications which may be in great demand by the people of the mainland and the people of Hong Kong."
Fraud & AML In Asia: What Banks Need To Know In 2026
Fraud and AML in Asia have shifted over the past year. Alongside the system-level attacks that continue, panellists poi... Read more
Hong Kongs Total AUM Hits Record HK$42.2 Trillion In 2025
According to the Securities and Futures Commission (SFC), Hong Kong’s total assets under management (AUM) reached a r... Read more
Hyundai Card Leverages Apple Pay To Target Gen Z Users
Hyundai Card launched six new debit and hybrid cards tailored to Apple Pay users in April. The South Korean issuer is t... Read more
DBS And Samsung Securities Partner For Global Wealth Expansion
DBS has signed a MoU with South Korea’s Samsung Securities to establish a strategic partnership in wealth management.... Read more
RedotPay Selects OpenPayd For Treasury Operations And Global Remittances
RedotPay has selected OpenPayd to enhance its treasury operations and cross-border remittance services. The company wil... Read more
JCB Rolls Out Contactless Transit Payments Across Taipei Metro
JCB has rolled out contactless payment acceptance on the Taipei Metro. The integration allows cardholders to tap physic... Read more
